Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huayu Qiangshen Tongbi optimization C decoction granules is a traditional Chinese medicine (TCM) formulation developed by the Guangdong Provincial Hospital of Chinese Medicine for the treatment of rheumatoid arthritis. It is a specific "optimization C" variant of the Huayu Qiangshen Tongbi formula, which is designed to address the TCM patterns of dampness syndrome and blood stasis while strengthening the kidneys. In clinical research, it is utilized as part of a dampness-removing regimen in combination with Shenlingbaizhu powder and methotrexate. The therapy aims to prevent the recurrence of rheumatoid arthritis and maintain low disease activity in patients who might otherwise require biologic therapies such as adalimumab.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huayu Qiangshen Tongbi optimization C decoction granules.